We spoke with Guido Baechler, CEO & Director of Mainz BioMed, a newly  listed company (NASDAQ : MYNZ) behind the breakthrough product Colo Alert, an early-detection cancer screening tool. Guido discusses his background in biotech, the talented team at Mainz driving their success, and the road to FDA approval for a product already approved and commercially distributed throughout the EU.   

Dylan Berg  Founder, Dear Retail 

Twitter: @Dylan_berg 

www.dearretailinvestors.com  

Guido Baechler CEO & Director, Mainz BioMed 

mainzbiomed.com 

Nasdaq: MYNZ